Infignos Media -- buyersUSA Consulting
NOW PLAYING
15 Radio Streams
Click Here
Tangible Investment Group
Advertise Here

From Government, Legal and Policy - Legal Issues

Brought to you by Batteries Unlimited

Your local source for just about every battery you can imagine. Call us first at 256-238-9005.

Erectile Dysfunction

CRESTOR US Patent Upheld by Court of Appeals for the Federal Circuit

Mon, 17 Dec 2012 10:47:29 EST

AstraZeneca announced today that the Court of Appeals for the Federal Circuit has upheld the decision of the District Court, District of Delaware, finding that the US substance patent protecting CRESTOR (rosuvastatin calcium) (RE37,314 – the '314 patent) is valid and enforceable. The defendants may seek a rehearing and/or review by the U.S. Supreme Court. Absent a reversal of this decision, none of the Abbreviated New Drug Applications (ANDAs) filed by Apotex, Aurobindo, Cobalt, Glenmark, Mylan, Par, Sandoz, Sun, Teva and Torrent may be approved by the FDA prior to expiration of the '314 patent. The '314 patent, which expires in 2016, covers rosuvastatin calcium, the active ingredient in CRESTOR.

The Federal Circuit also held that Apotex Corp. was liable as a submitter and is therefore bound by the District Court's decision.

NOTES TO EDITORS

About the Trial

Beginning in 2007, nine generic drug manufacturers filed ANDAs along with Paragraph IV certifications of non-infringement, invalidity, or unenforceability with respect to the CRESTOR '314 substance patent. AstraZeneca and Shionogi (the owner of the '314 patent) filed patent infringement suits against eight manufacturers (various parent or subsidiary entities of Apotex, Aurobindo, Cobalt, Mylan, Par, Sandoz, Sun and Teva) who had challenged the '314 substance patent. These suits were consolidated by order of the Judicial Panel on Multidistrict Litigation and tried in the U.S. District Court, District of Delaware. Trial commenced on February 22, 2010 before Judge Farnan and ended on March 3, 2010.

In June 2010, the US District Court for the District of Delaware found the '314 patent valid and enforceable and infringed by the eight generic defendants.

About AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com.


Source: WebWire



From Our Blogs

New Ways to Volunteer in Your Community and Beyond

There are a variety of new ways you can make an impact in your community.

Ways to Keep Your Community Safer

As an average citizen, there are several steps you can take to make your community safer.

Tips to Make Playtime Educational and Fun

Playtime should be fun and educational.

How to Turn Personal Obstacles into Triumphs

Young is offering insights into how to turn your impediments into assets.


Sign up for our weekly newsletter.

Our Website Sponsors

Valley Heating and Cooling

It's hard to stop a Trane. Your local heating and cooling company. Located in Saks at 521 Post Oak Road. Call us at 256-820-3369.

Sunny King Toyota

Sunny King Toyota has received almost as many accolades as our Toyotas,including more than 25 prestigious industry awards from Toyota and Southeast Toyota. Stop by to see how all of this can benefit you! 2570 US Hwy 78 E, Anniston.1-800-365-3001

Allstate Insurance- Jerry McCullers

As a Personal Financial Representative in Anniston, I know many local families and can help with all of your insurance needs. Call me at 256-237-1100.

Sunny King Honda

Come in for special pricing and financing. Special APR as low as 0.9%. 2580 US Highway 78 East, Anniston. 256-343-4216. www.SunnyKingHonda.com.

ERA King Real Estate

We bring the world to Alabama's doorstep. Offices in Birmingham, Anniston, Gadsden, and Lincoln. Call us at 256-831-5656 or visit us at eraking.com.